News Links
Celiac News for December 28, 2016
Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients. Less Hidden Celiac Disease But Increased Gluten Avoidance Without a Diagnosis in the United States: Findings From the National Health and Nutrition Examination Surveys From 2009 to 2014.
Read MoreDaily Care News for December 28, 2016
Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes. Mitigating Reductions in Glucose During Exercise on Closed-Loop Insulin Delivery: The Ex-Snacks Study. Physical activity and sedentary behavior levels in children and adolescents with type 1 diabetes using insulin pump or injection therapy – The importance of parental activity profile. Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes. The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial. […]
Read MoreResearch News From December 28, 2016
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. See also Bionic pancreas system manages blood sugar levels in patients with type 1 diabetes living at home. Aggregation of Engineered Human β-Cells Into Pseudoislets: Insulin Secretion and Gene Expression Profile in Normoxic and Hypoxic Milieu. Free full text available in HTML and PDF formats. Vitamin D on Early Stages of Diabetic Kidney Disease: A Cross-sectional Study in Patients with Type 1 Diabetes Mellitus.
Read MorePress Releases for December 21, 2016
FDA Approval of Dexcom’s Non-Adjunctive Indication Triggers a New Era in Diabetes Management. The Dexcom G5 Mobile CGM System is the first and only medical device that is FDA-approved for making daily diabetes decisions without painful finger pricks. See also FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. Bionic pancreas system successfully controls blood sugar without risk of hypoglycemia. Novo Nordisk Receives FDA Approval of Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) for Use in Children and Adolescents With Diabetes. See also Tresiba gets FDA approval to treat children with type 1 […]
Read MorePopular Press for December 21, 2016
ETSU doctor studies reliability of diabetes alert dogs. Bionic pancreas system manages blood sugar levels in patients with type 1 diabetes living at home. Were Pet Owners Scammed Out Of Thousands Of Dollars By A Service Dog Company? (Click on video links to view segments from the show.) Irish mum with two diabetic kids urges parents to know the symptoms.
Read MoreLegislative and Policy News for December 21, 2016
Leading diabetes group joins opposition to Obamacare repeal.
Read MoreCeliac News for December 21, 2016
Abdominal Pain-Associated Functional Gastrointestinal Disorder Prevalence in Children and Adolescents with Celiac Disease on Gluten-Free Diet: A Multinational Study. Adult Celiac Disease: Patients Are Shorter Compared with Their Peers in the General Population. Free full text available in HTML and PDF formats.
Read MoreDaily Care News for December 21, 2016
Real Time Continuous Glucose Monitoring in type 1 diabetes: A Systematic review and Individual Patient Data Meta-Analysis. Pediatric parenting stress in fathers and mothers of young children with Type 1 diabetes: a longitudinal study. Active Subjects with Autoimmune Type 1 Diabetes Have Better Metabolic Profiles than Sedentary Controls.
Read More